$39.41
-0.57-1.43%
Medline fell 2.5% from $41.00 to $39.98, behind the S&P 500's +12.8%. Its worst day was Aug 5 (−12.8%), and its low came Sep 18 at $31.64.
Dec 17, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.01 missed the $0.24 estimate on $7.8B revenue (est. $7.5B).
−3.6% · S&P 500 +0.8%
EPS of $0.33 beat the $0.29 estimate on $7.4B revenue (est. $7.2B).
Story events cover the past 12 months · Times ET
−7.3% · S&P 500 +1.4%
EPS of $0.50 beat the $0.32 estimate on $7.7B revenue (est. $7.5B).
−12.8%, the year's worst day · S&P 500 −0.2%
Medline closed at its lowest level of the year, 22.8% below where the year started.
−1.5% · S&P 500 +0.1%
EPS of $0.44 beat the $0.34 estimate on $7.9B revenue (est. $7.7B).
+18.4%, the year's best day · S&P 500 +1.7%
Where it ended: a close of $39.98 on Nov 12, 2026. Up next: Q4 2026 earnings on Feb 18, 2027 (EPS est. $0.39, revenue est. $8.5B).
Nothing in the past 12 months.
All MDLN dividend historyReplay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for MDLN and SPY from Benzinga historical bars. Not investment advice.